GLP-1 receptor antagonist as a potential probe for pancreatic β-cell imaging
- 20 November 2009
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 389 (3), 523-526
- https://doi.org/10.1016/j.bbrc.2009.09.014
Abstract
No abstract availableKeywords
Funding Information
- Kyoto University
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 14 references indexed in Scilit:
- Molecular imaging targeting peptide receptorsMethods, 2009
- Pancreatic β‐cell mass in European subjects with type 2 diabetesDiabetes, Obesity and Metabolism, 2008
- An examination of β‐cell function measures and their potential use for estimating β‐cell massDiabetes, Obesity and Metabolism, 2008
- Efforts to develop methods forin vivoevaluation of the native β-cell massDiabetes, Obesity and Metabolism, 2008
- The Physiology of Glucagon-like Peptide 1Physiological Reviews, 2007
- Biology of Incretins: GLP-1 and GIPGastroenterology, 2007
- A new technique for in vivo imaging of specific GLP-1 binding sites: First results in small rodentsRegulatory Peptides, 2006
- A model for receptor–peptide binding at the glucagon‐like peptide‐1 (GLP‐1) receptor through the analysis of truncated ligands and receptorsBritish Journal of Pharmacology, 2003
- Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patientsDiabetologia, 2002
- ISOLATION OF RAT PANCREATIC ISLETS BY DUCTAL INJECTION OF COLLAGENASE1Transplantation, 1986